Recommendations from the ICM-VTE: General
The ICM-VTE General Delegates
Abstract
Update This article was updated on June 17, 2022 because of a previous error. On page 33, in the section entitled “17 - Does administration of tranexamic acid (TXA) to patients undergoing orthopaedic procedures increase the risk of subsequent VTE?”, and in the note on page 161, the name “Armin Arish” now reads “Armin Arshi.” An erratum has been published: J Bone Joint Surg Am. 2022 Aug 3;104(15):e69.
Topics & Concepts
Tranexamic acidSection (typography)MedicineSurgeryComputer scienceOperating systemBlood lossVenous Thromboembolism Diagnosis and ManagementTotal Knee Arthroplasty OutcomesBlood transfusion and management